Loading cancer entity…
Loading cancer entity…
Clinical trials
175 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06679816 | Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors | recruiting | Phase 4 | 882 | Beijing Tiantan HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06752824 | Analgesia Nociception Index (ANI) in Intracranial Surgical Anesthesia(ANI) | completed | — | 75 | Trakya UniversityOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT03677713 | Nasal Packing Following Endoscopic Endonasal Pituitary Resection | completed | N/A | 60 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05254197 | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)(SOLOMON) | recruiting | — | 3,000 | Seoul National University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT06701838 | Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection(OPTIMAL) | not yet recruiting | — | 15 | Imperial College LondonOTHER | 0 | Dec 3, 2024 | clinicaltrials |
| NCT06705036 | Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions | recruiting | — | 20 | Shanghai Zhongshan HospitalOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT05448690 | Comparative Effectiveness of Different Surgical Approaches for Giant Pituitary Adenomas | completed | N/A | 600 | Huashan HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06664190 | Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency | active not recruiting | — | 200 | Huashan HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT01794793 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | completed | Phase 4 | 337 | RECORDATI GROUPINDUSTRY | 28 | Oct 1, 2024 | clinicaltrials |
| NCT06282224 | Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery | recruiting | N/A | 10 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06556186 | Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma | not yet recruiting | N/A | 600 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Aug 15, 2024 | clinicaltrials |
| NCT06526481 | Nasoseptal Double Flap Versus Rescue Flap in Endoscopic Transsphenoidal Pituitary Surgery | completed | N/A | 56 | Mansoura UniversityOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06523582 | Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients | recruiting | — | 750 | Universidad Nacional Autonoma de MexicoOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT03636568 | Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)(DHAPS) | completed | N/A | 300 | Washington University School of MedicineOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT01556230 | Prospective Study of Clinically Nonfunctioning Pituitary Adenomas(PAPS) | completed | — | 292 | Columbia UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06472505 | Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06326853 | Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models | not yet recruiting | — | 200 | IRCCS San RaffaeleOTHER | 0 | Jun 11, 2024 | clinicaltrials |
| NCT03038308 | Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole | completed | Phase 1 / Phase 2 | 16 | Columbia UniversityOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05236829 | Exercise Capacity and Physical Activity Level in Prolactinoma Patients | completed | — | 38 | Hacettepe UniversityOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT05727605 | Neurocognition After Radiotherapy in CNS- and Skull-base Tumors(NARCiS) | recruiting | N/A | 120 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05659524 | Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery(NOSE) | recruiting | N/A | 140 | Lori WoodOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06156020 | Outcome Analysis of Endoscopic Resection of Pituitary Adenomas | unknown | N/A | 500 | National Cheng-Kung University HospitalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06234553 | Application of Radiomics in the Diagnosis and Treatment Prediction of Pituitary Adenoma(RIPA) | unknown | — | 200 | Beijing Tiantan HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT03284775 | Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma | completed | N/A | 5 | University College, LondonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06053437 | Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.(Hyp'Op) | completed | — | 211 | Central Hospital, Nancy, FranceOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT06015802 | Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors | recruiting | — | 300 | Sun Yat-sen UniversityOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT01689727 | Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors | completed | Phase 2 | 40 | EndocyteINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05088252 | Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection | completed | N/A | 112 | Beijing Tiantan HospitalOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT03515603 | Endocrine Outcome of Surgery for Pituitary Adenoma | terminated | N/A | 36 | University of UlmOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT04212793 | Detection of PitNET Tissue During TSS Using Bevacizumab-800CW(DEPARTURE) | completed | Phase 1 | 20 | University Medical Center GroningenOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05338125 | Electrophysiology of the Human Pituitary Gland | terminated | N/A | 1 | Leiden University Medical CenterOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome(PPB) | completed | — | 1,247 | Ashley HillOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT05466357 | Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas | unknown | N/A | 30 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT04782596 | Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions | completed | N/A | 30 | University Hospital OstravaOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05634655 | Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors. | unknown | — | 500 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05108064 | Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning | unknown | — | 1,000 | Huashan HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT03930771 | Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas(TMZ-Cap) | terminated | Phase 2 | 1 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT03624114 | Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery(Scope) | completed | — | 40 | University Hospital, Basel, SwitzerlandOTHER | 2 | Aug 3, 2022 | clinicaltrials |
| NCT04369703 | Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery | completed | — | 199 | Mayo ClinicOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT04863339 | Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery | withdrawn | Phase 2 | 0 | University of North Carolina, Chapel HillOTHER | 0 | Apr 5, 2022 | clinicaltrials |
| NCT02419664 | Ga-68-DOTATOC -PET in the Management of Pituitary Tumours | terminated | Phase 3 | 22 | Göteborg UniversityOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04076046 | Multicentric Prospective Validation of the Zurich Pituitary Score | completed | — | 408 | University of ZurichOTHER | 6 | Dec 17, 2021 | clinicaltrials |
| NCT04284605 | Effects Exercise Training in Patients With Pituitary Adenoma | completed | N/A | 10 | Hacettepe UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT02351700 | Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors | completed | Phase 4 | 62 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT03973450 | Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia(EpidemioPIT) | unknown | — | 400 | Neuromed IRCCSOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04951557 | Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas | unknown | — | 5,000 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT04938401 | Construction and Application of a Risk Prediction Model Forepistaxis After Pituitary Tumor Resection | unknown | — | 1 | Wang Ying supervisor nurseOTHER | 0 | Jun 24, 2021 | clinicaltrials |
| NCT04840771 | Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery | completed | — | 8 | Federico II UniversityOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT04863456 | Efficiency and Safety of Different Treatment Strategies in Adults With Pituitary Adenomas With Hypothalamic Involvement | unknown | N/A | 90 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Apr 28, 2021 | clinicaltrials |
| NCT02749227 | Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors(PASSILCORT) | terminated | Phase 2 | 4 | Columbia UniversityOTHER | 1 | Apr 27, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jan 14, 2025source: clinicaltrials